July 25, 2024

Circulating tumour DNA in patients with hepatocellular carcinoma across tumour stages and treatments

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Circulating tumour DNA (ctDNA) is a promising non-invasive biomarker in cancer. We aim to assess the dynamic of ctDNA in patients with hepatocellular carcinoma (HCC).

Preguntar a la IA

Me gusta

Guardar

Cite This Study

Campani et al. (Thu,) studied this question.

synapsesocial.com/papers/68e5f0a2b6db6435875850b1 https://doi.org/https://doi.org/10.1136/gutjnl-2024-331956

Preguntar a la IA

Me gusta

Guardar